VAERS reports by lot

Novartis Vaccines Meningococcal lot ABXA87AZ: VAERS reports

33 VAERS reports list lot ABXA87AZ as a Novartis Vaccines Meningococcal vaccine, received between 2021-07-20 and 2022-08-27. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
33
Reports
0%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)919%
Neurological817%
Injection-site / Local reaction817%
Gastrointestinal715%
Musculoskeletal612%
Allergic / Anaphylactic48%
Respiratory24%
Dermatological (non-injection-site)24%
Cardiac / Cardiovascular12%
Reproductive / Menstrual12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Wisconsin4
Pennsylvania3
Texas3
Iowa3
Colorado3
Ohio2
Michigan2
Montana2
Maryland1
Massachusetts1
New Jersey1
Wyoming1

Reports by month received

2021-073
2021-086
2021-093
2021-121
2022-011
2022-0210
2022-043
2022-051
2022-062
2022-071
2022-082

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.